US Stock MarketDetailed Quotes
APPB APPLIED BIOSCIENCES CORP
- 0.000200
- 0.0000000.00%
15min DelayTrading Aug 13 16:00 ET
4.40KMarket Cap-1P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.000200Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)22.00MShares0.00020052wk High0.01P/B3.02KFloat Cap0.00020052wk Low--Dividend TTM15.10MShs Float0.440000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low--Avg Price1Lot Size
APPLIED BIOSCIENCES CORP Key Stats
Quarterly+Annual
YOY
| (Q3)Dec 31, 2019 | (Q2)Sep 30, 2019 | (Q1)Jun 30, 2019 | (FY)Mar 31, 2019 | (Q4)Mar 31, 2019 | (Q3)Dec 31, 2018 | (Q2)Sep 30, 2018 | (Q1)Jun 30, 2018 | (FY)Mar 31, 2018 | (Q4)Mar 31, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 89.47%-52.14K | -178.78%-366.53K | -146.27%-399.04K | -34.39%-905.05K | 54.03%-116.19K | -135.33%-495.35K | 11.66%-131.47K | -163.96%-162.04K | -389.92%-673.47K | -264.17%-252.77K |
| Net income from continuing operations | 24.62%-1.43M | -651.79%-855.23K | -26.43%-507.93K | -12.24%-2.68M | 83.71%-271.96K | -451.70%-1.89M | 35.88%-113.76K | -103.73%-401.76K | -362.64%-2.39M | -2,251.03%-1.67M |
| Operating gains losses | --366.61K | ---- | ---- | ---429.76K | ---24.99K | --0 | ---245.83K | ---158.93K | ---- | ---- |
| Depreciation and amortization | 21,463.36%62.97K | 13,465.53%39.75K | 13,466.21%39.75K | -81.93%40.63K | -29.45%39.75K | -99.48%292 | -99.48%293 | -99.48%293 | 1,026.33%224.77K | --56.34K |
| Other non cash items | -52.90%371.66K | -71.77%28.94K | -88.77%21.96K | 263.90%847.08K | -299.29%-240.03K | 1,165.85%789.04K | --102.51K | 291.12%195.56K | -38.15%232.78K | --120.45K |
| Change In working capital | 427.85%489.78K | 177.31%347.52K | -89.06%22.18K | 2,107.12%257.27K | 372.52%78.55K | -1,178.02%-149.39K | 554.99%125.32K | 583.05%202.8K | 28.25%-12.82K | -57.01%-28.82K |
| -Change in receivables | -78.81%-12.08K | -486.50%-10.59K | 5,485.48%76.42K | -243.15%-23.02K | -128.36%-17.59K | -254.13%-6.76K | -27.34%2.74K | 80.19%-1.42K | -18.18%-6.71K | -278.14%-7.7K |
| -Change in inventory | 122.47%4.14K | 256.08%9.69K | -44.62%-36.62K | -679.03%-49.66K | -245.56%-8.63K | -295.81%-18.43K | 116.74%2.72K | -394.03%-25.32K | 62.13%-6.38K | 135.23%5.93K |
| -Change in prepaid assets | 107.84%2.34K | 1,295.42%27.15K | -84.98%16.49K | 19,973.17%294.07K | 2,037.96%216.37K | -364.94%-29.8K | 57.66%-2.27K | 1,527.20%109.77K | 108.66%1.47K | 34.01%-11.17K |
| -Change in payables and accrued expense | 624.77%495.39K | 163.06%321.27K | -128.48%-34.11K | 734.36%35.89K | -602.50%-111.61K | -1,226.10%-94.4K | 1,360.22%122.13K | 457.15%119.77K | -80.06%4.3K | -243.48%-15.89K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---5.5K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 89.47%-52.14K | -178.78%-366.53K | -146.27%-399.04K | -34.39%-905.05K | 54.03%-116.19K | -135.33%-495.35K | 11.66%-131.47K | -163.96%-162.04K | -389.92%-673.47K | -264.17%-252.77K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -311.75%-713.29K | -58.34%-163.29K | 77.65%-173.24K | 72.50%-103.13K | ||||||
| Net PPE purchase and sale | ---- | ---- | ---- | 66.91%-1.56K | ---- | ---- | ---- | ---- | ---4.7K | ---3.13K |
| Net business purchase and sale | ---- | ---- | ---- | ---711.74K | -335.99%-161.74K | ---- | ---- | ---- | --0 | --68.54K |
| Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 73.03%-168.54K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | -311.75%-713.29K | -58.34%-163.29K | ---- | ---- | ---- | 77.65%-173.24K | 72.50%-103.13K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 197.78%402K | 273.15%389.94K | 130.86%1.6M | 84.96K | 156.03%1.28M | -30.79%135K | 104.5K | -38.23%695K | 0 |
| Net issuance payments of debt | --0 | 197.78%402K | 1,221.83%389.94K | --1.53M | --84.96K | --1.28M | --135K | --29.5K | --0 | --0 |
| Net common stock issuance | --0 | --0 | --0 | -89.21%75K | --0 | --0 | --0 | --75K | -38.23%695K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 197.78%402K | 273.15%389.94K | 130.86%1.6M | --84.96K | 156.03%1.28M | -30.79%135K | --104.5K | -38.23%695K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 960.25%73.41K | 1,016.54%37.94K | -22.80%47.04K | -71.34%60.93K | -42.05%241.57K | -95.31%6.92K | -96.64%3.4K | -71.34%60.93K | --212.64K | 53.22%416.83K |
| Current changes in cash | -122.22%-52.14K | 906.01%35.47K | 84.18%-9.1K | 90.84%-13.89K | 45.34%-194.53K | -12.88%234.65K | -92.37%3.53K | 48.35%-57.54K | -171.34%-151.7K | -499.06%-355.9K |
| End cash Position | -91.20%21.27K | 960.25%73.41K | 1,016.54%37.94K | -22.80%47.04K | -22.80%47.04K | -42.05%241.57K | -95.31%6.92K | -96.64%3.4K | -71.34%60.93K | -71.34%60.93K |
| Free cash flow | 89.47%-52.14K | -178.78%-366.53K | -146.27%-399.04K | -33.68%-906.61K | 53.99%-117.74K | -133.59%-495.35K | 11.66%-131.47K | -163.96%-162.04K | -135.91%-678.17K | -16.63%-255.9K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data